Primary cultured astrocytes from old rats are capable to activate the Nrf2 response against MPP+ toxicity after tBHQ pretreatment

Neurobiology of Aging

Volumn 35, Issue 8, 2014, Pages 1901-1912

  Alarcón Aguilar, Adriana ^a   Luna López, Armando ^b   Ventura Gallegos, José L ^c,d   Lazzarini, Roberto ^a   Galván Arzate, Sonia ^b   González Puertos, Viridiana Y ^a   Morán, Julio ^c   Santamaría, Abel ^b   Königsberg, Mina ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d Departamento de Bioquímica INCMNZS   (Mexico)

Author keywords

Aging; Antioxidant enzymes; Astrocytes; GSH; Nrf2; Oxidative stress; Primary cultures; TBHQ

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ANTIOXIDANT; NEUROTOXIN; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; 2-TERT-BUTYLHYDROQUINONE; HYDROQUINONE DERIVATIVE; NFE2L2 PROTEIN, RAT;

ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL PROTECTION; ENZYME ACTIVATION; FRONTAL CORTEX; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FRONTAL LOBE; METABOLISM; PHYSIOLOGY; TOXICITY; WISTAR RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ASTROCYTES; CELLS, CULTURED; FRONTAL LOBE; HYDROQUINONES; NEUROTOXINS; NF-E2-RELATED FACTOR 2; RATS; RATS, WISTAR;

EID: 84899914585     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.01.143     Document Type: Article

References (63)

1. Alarcón-Aguilar A., González-Puertos V.Y., Luna-López A., Morán J., Santamaría A., Königsberg M. Comparing the effects of two neurotoxins in cortical astrocytes from newborn and adult rats: involvement of oxidative damage. J.Appl. Toxicol. 2014, 34:127-138.
2. Bradford M.M. Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Calabrese E.J. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. J.Ageing Res. Rev. 2008, 7:8-20.
4. Chen H., Wang S., Ding J.H., Hu G. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway. J.Neurochem. 2008, 106:2345-2352.
5. Darlington C.L. Astrocytes as targets for neuroprotective drugs. Curr. Opin. Investig. Drugs 2005, 6:700-703.
6. Dhakshinamoorthy S., Jain A.K., Bloom D.A., Jaiswal A.K. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J.Biol. Chem. 2005, 280:16891-16900.
7. Di Monte D.A., Wu E.Y., Langston J.W. Role of astrocytes in MPTP metabolism and toxicity. Ann. N.Y. Acad. Sci. 1992, 11:219-228.
8. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
9. Erlank H., Elmann A., Kohen R., Kanner J. Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones. Free Radic. Biol. Med. 2011, 51:2319-2327.
10. Fernández-Checa J.C., García-Ruiz C. Glutation. Radicales Libres Y Estrés Oxidativo: Aplicaciones Médicas 2008, 253-267. El Manual Moderno, Mexico City. M. Konigsberg (Ed.).
11. Forman H.J., Fukuto J.M., Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell.Physiol. 2004, 287:246-256.
12. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N.Engl. J. Med. 2003, 348:1365-1375.
13. Galván-Arzate S., Pedraza-Chaverrí J., Medina-Campos O.N., Maldonado P.D., Vázquez-Román B., Ríos C., Santamaría A. Delayed effects of thallium in the rat brain: regional changes in lipid peroxidation and behavioral markers, but moderate alterations in antioxidants, after a single administration. Food Chem. Toxicol. 2005, 43:1037-1045.
14. García-Matas S., Gutierrez-Cuesta J., Coto-Montes A., Rubio-Acero R., Díez-Vives C., Camins A., Pallàs M., Sanfeliu C., Cristòfol R. Dysfunction of astrocytes in senescence-accelerated mice SAMP8 reduces their neuroprotective capacity. Aging Cell 2008, 7:630-640.
15. Gharavi N., Haggarty S., El-Kadi A.O. Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites. Curr. Drug Metab. 2007, 8:1-7.
16. Gómez-Quiroz L.E., Factor V.M., Kaposi-Novak P., Coulouarn C., Conner E.A., Thorgeirsson S.S. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J. Biol. Chem. 2008, 283:14581-14589.
17. Gottfried C., Tramontina F., Goncalves D., Goncalves C.A., Moriguchi E., Dias R.D., Wofchuck S.T., Souza D.O. Glutamate uptake in cultured astrocytes depends on age: a study about the effect of guanosine and the sensitivity to oxidative stress induced by H2O2. Mech. Ageing Dev. 2002, 123:1333-1340.
18. Harman D. The free radical theory of aging. Antioxid. Redox Signal. 2003, 5:557-561.
19. Imhoff B.R., Hansen J.M. Tert-butylhydroquinone induces mitochondrial oxidative stress causing Nrf2 activation. Cell. Biol. Toxicol. 2010, 26:541-551.
20. Jakel R.J., Townsend J.A., Kraft A.D., Johnson J.A. Nrf2-mediated protection against 6-hydroxydopamine. Brain Res. 2007, 1144:192-201.
21. Jones P.D. Radical-free biology of oxidative stress. Am. J. Physiol. Cell. Physiol. 2008, 295:849-868.
22. Kahlert S., Reiser G. Glial perspectives of metabolic states during cerebral hypoxia-calcium regulation and metabolic energy. Cell Calcium 2004, 36:295-302.
23. Kanwar S.S., Nehru B. Modulatory effects of N-acetylcysteine on cerebral cortex and cerebellum regions of ageing rat brain. Nutr. Hosp. 2007, 22:95-100.
24. Kaspar J.W., Jaiswal A.K. An auto regulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance. J.Biol. Chem. 2010, 285:21349-21358.
25. Kim S.U., De Vellis J. Microglia in health and disease. J.Neurosci. Res. 2005, 81:302-313.
26. Klamt F., Gottfried C., Tramontina F., Dal-Pizzol F., Conte da Frota M.L., Fonseca Moreira J.C., Dias R.D., Moriguchi E., Wofchuck S., Souza D.O. Time-related increase in mitochondrial superoxide production, biomolecule damage and antioxidant enzyme activities in cortical astrocyte cultures. Neuroreport 2002, 13:1515-1518.
27. Kraft A.D., Johnson D.A., Johnson J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J.Neurosci. 2004, 24:1101-1112.
28. Krueger M.J., Singer T.P., Casida J.E., Ramsay R.R. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone. Biochem. Biophys. Res. Commun. 1990, 169:123-128.
29. Kweon M.H., In-Park Y., Sung H.C., Mukhtar H. The novel antioxidant 3-O-caffeoyl-1- methylquinic acid induces Nrf2-dependent phase II detoxifying genes and alters intracellular glutathione redox. Free Radic. Biol. Med. 2006, 40:1349-1361.
30. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J.Biol. Chem. 2003, 278:12029-12038.
31. Lee O.H., Jain A.K., Papusha V., Jaiswal A.K. An auto-regulatory loop between stress sensors Inrf2 and Nrf2 controls their cellular abundance. J.Biol. Chem. 2007, 282:36412-36420.
32. Li J., Johnson D., Calkins M., Wright L., Svendsen C., Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 2005, 8:313-328.
33. Liddell J.R., Robinson S.R., Dringen R., Bishop G.M. Astrocytes retain their antioxidant capacity into advanced old age. Glia 2010, 58:1500-1509.
34. Lin D.T., Wu J., Holstein D., Upadhyay G., Rourk W., Muller E., Lechleiter J.D. Ca2+ signaling, mitochondria and sensitivity to oxidative stress in aging astrocytes. Neurobiol. Aging 2007, 28:99-111.
35. Liu R.M. Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J.Neurosci. Res. 2002, 68:344-351.
36. López-Diazguerrero N.E., López-Araiza H., Conde-Pérezprina J.C., Bucio L., Cárdenas M.C., Ventura J.L., Covarrubias L., Gutiérrez-Ruiz M.C., Zentella A., Königsberg M. Bcl-2 protects against oxidative stress while inducing premature senescence. Free Radic. Biol. Med. 2006, 40:1161-1169.
37. Luna-López A., Triana-Martínez F., López-Diazguerrero N.E., Ventura-Gallegos J.L., Gutiérrez-Ruiz M.C., Damián-Matsumura P., Zentella A., Gómez-Quiroz L.E., Königsberg M. Bcl-2 sustains hormetic response by inducing Nrf2 nuclear translocation in L929 mouse fibroblasts. Free Radic. Biol. Med. 2010, 49:1192-1204.
38. Luna-López A., González-Puertos V.Y., Romero-Ontiveros J., Ventura-Gallegos J.L., Zentella A., Gomez-Quiroz L.E., Königsberg M. A noncanonical NF-κB pathway through the p50 subunit regulates Bcl-2 overexpression during an oxidative conditioning hormesis response. Free Radic. Biol. Med. 2013, 63:41-50.
39. Mattson M.P. Hormesis defined. Ageing Res. Rev. 2008, 7:1-7.
40. McCarthy K.F., De Villes J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J.Cell. Biol. 1980, 85:890-902.
41. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
42. Niture S.K., Kaspar J.W., Shen J., Jaiswal A.K. Nrf2 signaling and cell survival. Toxicol. Appl. Pharmacol. 2010, 244:37-42.
43. Niture S.K., Jain A.K., Jaiswal A.K. Antioxidant induced modification of INrf2- cysteine 151 and PKCδ- mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J.Cell Sci. 2009, 122:4452-4464.
44. Niture S.K., Jaiswal A.K. Prothymosin-alpha mediates nuclear import of the Inrf2/Cul3/Rbx1 complex to degrade nuclear Nrf2. J.Biol. Chem. 2009, 284:13856-13868.
45. Niture S.K., Jain A.K., Shelton P., Jaiswal A.K. Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression. J.Biol. Chem. 2011, 286:28821-28832.
46. Osburn W.O., Wakabayashi N., Misra V. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch. Biochem. Biophys. 2006, 454:7-15.
47. Papadopoulos M.C., Koumenis I.L., Yuan T.Y., Giffard R.G. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience 1998, 82:915-925.
48. Przedborski S., Vila M. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann. N.Y. Acad. Sci. 2003, 991:189-198.
49. Reynolds A., Laurie C., Mosley R.L., Gendelman H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82:297-325.
50. Schapira A.H., Olanow C.W. Drug selection and timing of initiation of treatment in early Parkinson's disease. Ann. Neurol. 2008, 2(64 Suppl):S47-S55.
51. Scheiber I.F., Dringen R. Astrocyte functions in the copper homeostasis of the brain. Neuroch. Int. 2013, 62:556-565.
52. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Ann. Rev. Pharmacol. Toxicol. 1996, 36:83-106.
53. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
54. Takuma K., Baba A., Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 2004, 72:111-127.
55. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventiveagent sulforaphane by oligonucleotide microarray. Cancer Res. 2002, 62:5196-5203.
56. Ting K.K., Brew B.J., Guillemin G.J. Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J.Neuroinflammation 2009, 6:36.
57. Tsai M.J., Lee E.H. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes. Glia 1994, 12:329-335.
58. Tsai M.J., Lee E.H. Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induced toxicity. Free Radic. Biol. Med. 1998, 23:705-713.
59. Wang B., Zhu X., Kim Y.T., Li J., Huang S., Saleem S., Li R., Xu Y., Dore S., Cao W. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic. Biol. Med. 2012, 52:928-936.
60. Yan D., Dong J., Sulik K.K., Chen S.Y. Induction of the Nrf2-driven antioxidant response by tert-butylhydroquinone prevents ethanol-induced apoptosis in cranial neural crest cells. Biochem. Pharmacol. 2010, 80:144-149.
61. Zhang D., Hu X., Qian L., O'Callaghan J.P., Hong J.S. Astrogliosis in CNS is there a role for microglia?. Mol. Neurobiol. 2010, 41:232-241.
62. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 2003, 23:8137-8151.
63. Zhu Y., Carvey P.M., Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006, 1090:35-44.